The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Campylobacter Species and Guillain-Barré Syndrome
Open accessAbstract
SUMMARY: Since the eradication of polio in most parts of the world, Guillain-Barré syndrome (GBS) has become the most common cause of acute flaccid paralysis. GBS is an autoimmune disorder of the peripheral nervous system characterized by weakness, usually symmetrical, evolving over a period of several days or more. Since laboratories began to isolate Campylobacter species from stool specimens some 20 years ago, there have been many reports of GBS following Campylobacter infection. Only during the past few years has strong evidence supporting this association developed. Campylobacter infection is now known as the single most identifiable antecedent infection associated with the development of GBS. Campylobacter is thought to cause this autoimmune disease through a mechanism called molecular mimicry, whereby Campylobacter contains ganglioside-like epitopes in the lipopolysaccharide moiety that elicit autoantibodies reacting with peripheral nerve targets. Campylobacter is associated with several pathologic forms of GBS, including the demyelinating (acute inflammatory demyelinating polyneuropathy) and axonal (acute motor axonal neuropathy) forms. Different strains of Campylobacter as well as host factors likely play an important role in determining who develops GBS as well as the nerve targets for the host immune attack of peripheral nerves. The purpose of this review is to summarize our current knowledge about the clinical, epidemiological, pathogenetic, and laboratory aspects of campylobacter-associated GBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Adams, R. D., & Victor, M. (1977) · Medical Entomology and Zoology · Cited by 1,718
Campylobacter enteritis: a "new" disease.
Skirrow, M. B. (1977) · BMJ · doi:10.1136/bmj.2.6078.9 · Cited by 1,440
van der Meché, F. G. A., Schmitz, P. I. M., & the Dutch Guillain–Barré Study Group* (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261705 · Cited by 1,143
Fisher, M. (1956) · New England Journal of Medicine · doi:10.1056/nejm195607122550201 · Cited by 1,069
Experimental Campylobacter jejuni Infection in Humans
Black, R. E., Levine, M. M., Clements, M. L., Hughes, T. P., & Blaser, M. J. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/157.3.472 · Cited by 1,044
Experimental Campylobacter Jejuni Infection in Humans
Black, R. E., Levine, M. M., Clements, M. L., Hughes, T. P., & Blaser, M. J. (1988) · doi:10.21236/ada265410 · Cited by 869
Plasmapheresis and acute Guillain‐Barre syndrome
The Guillain-Barré Syndrome Study Group (1985) · Neurology · doi:10.1212/wnl.35.8.1096 · Cited by 773
Ho, T. W., Mishu, B., Li, C. Y., Gao, C. Y., Cornblath, D. R., Griffin, J. W., Asbury, A. K., Blaser, M. J., & McKhann, G. M. (1995) · Brain · doi:10.1093/brain/118.3.597 · Cited by 764
Self-citationCampylobacter jejuni Infection and Guillain–Barré Syndrome
Rees, J. H., Soudain, S. E., Gregson, N. A., & Hughes, R. A. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332102 · Cited by 753
(1997) · The Lancet · doi:10.1016/s0140-6736(96)09095-2 · Cited by 733
THE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS
ASBURY, A. K., ARNASON, B. G., & ADAMS, R. D. (1969) · Medicine · doi:10.1097/00005792-196905000-00001 · Cited by 723
Chiba, A., Kusunoki, S., Obata, H., Machinami, R., & Kanazawa, I. (1993) · Neurology · doi:10.1212/wnl.43.10.1911 · Cited by 705
Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China
McKhann, G. M., Cornblath, D. R., Griffin, J. W., Ho, T. W., Li, C. Y., Jiang, Z., Wu, H. S., Zhaori, G., Liu, Y., Jou, L. P., et al. (1993) · Annals of Neurology · doi:10.1002/ana.410330402 · Cited by 625
Self-citationPenner, J. L., & Hennessy, J. N. (1980) · Journal of Clinical Microbiology · doi:10.1128/jcm.12.6.732-737.1980 · Cited by 623
(1997) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(97)80059-4 · Cited by 610
Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome
Chiba, A., Kusunoki, S., Shimizu, T., & Kanazawa, I. (1992) · Annals of Neurology · doi:10.1002/ana.410310619 · Cited by 562
AN ACUTE AXONAL FORM OF GUILLAIN-BARRÉE POLYNEUROPATHY
FEASBY, T. E., GILBERT, J. J., BROWN, W. F., BOLTON, C. F., HAHN, A. F., KOOPMAN, W. F., & ZOCHODNE, D. W. (1986) · Brain · doi:10.1093/brain/109.6.1115 · Cited by 538
Gatenby, J. B., & Tahmisian, T. N. (1957) · Journal of the Royal Microscopical Society · doi:10.1111/j.1365-2818.1957.tb02020.x · Cited by 534
Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma
Hafer‐Macko, C., Hsieh, S., Ho, T. W., Sheikh, K., Cornblath, D. R., Li, C. Y., McKhann, G. M., Asbury, A. K., & Griffin, J. W. (1996) · Annals of Neurology · doi:10.1002/ana.410400414 · Cited by 512
Self-citationYuki, N., Taki, T., Inagaki, F., Kasama, T., Takahashi, M., Saito, K., Handa, S., & Miyatake, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1771 · Cited by 504
Acute axonal polyneuropathy associated with anti‐GM 1 antibodies following Campylobacter enteritis
Yuki, N., Yoshino, H., Sato, S., & Miyatake, T. (1990) · Neurology · doi:10.1212/wnl.40.12.1900 · Cited by 477
Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors
Lior, H., Woodward, D. L., Edgar, J. A., Laroche, L. J., & Gill, P. (1982) · Journal of Clinical Microbiology · doi:10.1128/jcm.15.5.761-768.1982 · Cited by 460
Efficiency of plasma exchange in Guillain‐Barré syndrome: Role of replacement fluids
French Cooperative Group on Plasma Exchange in Guillain‐Barrk Syndrome (1987) · Annals of Neurology · doi:10.1002/ana.410220612 · Cited by 457
Clinical and Epidemiologic Features of Guillain‐Barré Syndrome
Hughes, R. A. C., & Rees, J. H. (1997) · The Journal of Infectious Diseases · doi:10.1086/513793 · Cited by 456
Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy
Hafer‐Macko, C. E., Sheikh, K. A., Li, C. Y., Ho, T. W., Cornblath, D. R., McKhann, G. M., Asbury, A. K., & Griffin, J. W. (1996) · Annals of Neurology · doi:10.1002/ana.410390512 · Cited by 416
Self-citationPathology of the motor‐sensory axonal Guillain‐Barré syndrome
Griffin, J. W., Li, C. Y., Ho, T. W., Tian, M., Gao, C. Y., Xue, P., Mishu, B., Cornblath, D. R., Macko, C., McKhann, G. M., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390105 · Cited by 403
Self-citationMacromolecular permeability across the blood-nerve and blood-brain barriers.
Poduslo, J. F., Curran, G. L., & Berg, C. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5705 · Cited by 377
Schembri, M. (2016) · European Society of Radiology · doi:10.1594/ecr2016/c-1350 · Cited by 367
Griffin, J. W., Li, C. Y., Ho, T. W., Xue, P., Macko, C., Gao, C. Y., Yang, C., Tian, M., Mishu, B., Cornblath, D. R., et al. (1995) · Brain · doi:10.1093/brain/118.3.577 · Cited by 366
Self-citationCampylobacter Jejuni: Current Status and Future Trends
Nachamkin, I., Blaser, M. J., & Tompkins, L. S. (1992) · Medical Entomology and Zoology · Cited by 359
Self-citationAnti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr� syndrome
Ho, T. W., Willison, H. J., Nachamkin, I., Li, C. Y., Veitch, J., Ung, H., Wang, G. R., Liu, R. C., Cornblath, D. R., Asbury, A. K., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2<168::aid-ana6>3.0.co;2-6 · Cited by 329
Self-citationGangliosides are neuronal ligands for myelin-associated glycoprotein.
Yang, L. J., Zeller, C. B., Shaper, N. L., Kiso, M., Hasegawa, A., Shapiro, R. E., & Schnaar, R. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.814 · Cited by 295
Immunopathogenesis and treatment of the guillain‐barré syndrome—part I
Hartung, H., Toyka, K. V., Pollard, J. D., & Harvey, G. K. (1995) · Muscle & Nerve · doi:10.1002/mus.880180202 · Cited by 288
Moran, A. P., Prendergast, M. M., & Appelmelk, B. J. (1996) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1996.tb00127.x · Cited by 284
A prospective study of acute idiopathic neuropathy. II. Antecedent events.
Winer, J. B., Hughes, R. A., Anderson, M. J., Jones, D. M., Kangro, H., & Watkins, R. P. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.5.613 · Cited by 284
Serum antibodies to gangliosides in guillain‐barré syndrome
Ilyas, A. A., Willison, H. J., Quarles, R. H., Jungalwala, F. B., Cornblath, D. R., Trapp, B. D., Griffin, D. E., Griffin, J. W., & McKhann, G. M. (1988) · Annals of Neurology · doi:10.1002/ana.410230503 · Cited by 272
A selective medium for isolating Campylobacter jejuni/coli.
Bolton, F. J., & Robertson, L. (1982) · Journal of Clinical Pathology · doi:10.1136/jcp.35.4.462 · Cited by 270
Rees, J. H., Gregson, N. A., & Hughes, R. A. C. (1995) · Annals of Neurology · doi:10.1002/ana.410380516 · Cited by 266
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome
Griffin, J. W., Li, C. Y., Macko, C., Ho, T. W., Hsieh, S. T., Xue, P., Wang, F. A., Cornblath, D. R., McKhann, G. M., & Asbury, A. K. (1996) · Journal of Neurocytology · doi:10.1007/bf02284784 · Cited by 262
Self-citationMcKhann, G. M., Cornblath, D. R., Ho, T., Griffin, J. W., Li, C. Y., Bai, A. Y., Wu, H. S., Yei, Q. F., Zhang, W. C., Zhaori, Z., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)90606-p · Cited by 261
Self-citationMiller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.
Willison, H. J., Veitch, J., Paterson, G., & Kennedy, P. G. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.2.204 · Cited by 257
Kuroki, S., Saida, T., Nukina, M., Haruta, T., Yoshioka, M., Kobayashi, Y., & Nakanishi, H. (1993) · Annals of Neurology · doi:10.1002/ana.410330304 · Cited by 247
Aspinall, G. O., McDonald, A. G., Pang, H., Kurjanczyk, L. A., & Penner, J. L. (1994) · Biochemistry · doi:10.1021/bi00167a032 · Cited by 210
Frequent presence of anti‐G Q1b antibody in Fisher's syndrome
Yuki, N., Sato, S., Tsuji, S., Ohsawa, T., & Miyatake, T. (1993) · Neurology · doi:10.1212/wnl.43.2.414 · Cited by 204
Guillain-Barré syndrome and Campylobacter jejuni: a serological study.
Kaldor, J., & Speed, B. R. (1984) · BMJ · doi:10.1136/bmj.288.6434.1867 · Cited by 204
Ho, T. W., Hsieh, S.-T., Nachamkin, I., Willison, H. J., Sheikh, K., Kiehlbauch, J., Flanigan, K., McArthur, J. C., Cornblath, D. R., McKhann, G. M., et al. (1997) · Neurology · doi:10.1212/wnl.48.3.717 · Cited by 187
Self-citationMishu, B., Ilyas, A. A., Koski, C. L., Vriesendorp, F., Cook, S. D., Mithen, F. A., & Blaser, M. J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00006 · Cited by 184
PRINCIPLES AND PRACTICE OF MEDICINE
Goldring, S. R. (1977) · Chest · doi:10.1016/s0012-3692(16)40581-7 · Cited by 184
N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome
Kusunoki, S., Chiba, A., Kon, K., Ando, S., Arisawa, K., Tate, A., & Kanazawa, I. (1994) · Annals of Neurology · doi:10.1002/ana.410350510 · Cited by 180
Acute idiopathic polyneuritis. An electron microscope study.
Prineas, J. W. (1972) · PubMed · Cited by 178
Yuki, N., Taki, T., Takahashi, M., Saito, K., Yoshino, H., Tai, T., Handa, S., & Miyatake, T. (1994) · Annals of Neurology · doi:10.1002/ana.410360517 · Cited by 172
Aspinall, G. O., Fujimoto, S., McDonald, A. G., Pang, H., Kurjanczyk, L. A., & Penner, J. L. (1994) · Infection and Immunity · doi:10.1128/iai.62.5.2122-2125.1994 · Cited by 164
Blood-free selective medium for isolation of Campylobacter jejuni from feces
Bolton, F. J., Hutchinson, D. N., & Coates, D. (1984) · Journal of Clinical Microbiology · doi:10.1128/jcm.19.2.169-171.1984 · Cited by 158
Role of Infection Due to Campylobacter jejuni in the Initiation of Guillain-Barre Syndrome
Mishu, B., & Blaser, M. J. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.1.104 · Cited by 156
Ilyas, A. A., Mithen, F. A., Dalakas, M. C., Chen, Z.-W., & Cook, S. D. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90217-9 · Cited by 155
Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release
Roberts, M. T. M., Vincent, A. C., Newsom–Davis, J., & Willison, H. J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92694-8 · Cited by 151
Guillain-Barre syndrome associated with Campylobacter infection.
Rhodes, K. M., & Tattersfield, A. E. (1982) · BMJ · doi:10.1136/bmj.285.6336.173 · Cited by 149
Vriesendorp, F. J., Mishu, B., Blaser, M. J., & Koski, C. L. (1993) · Annals of Neurology · doi:10.1002/ana.410340206 · Cited by 149
Jacobs, B. C., Endtz, H. P., van der Meché, F. G. A., Hazenberg, M. P., Achtereekte, H. A. M., & van Doorn, P. A. (1995) · Annals of Neurology · doi:10.1002/ana.410370218 · Cited by 146
Koski, C. L., Humphrey, R. L., & Shin, M. L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.905 · Cited by 144
Saida, K., Saida, T., Brown, M. J., & Silberberg, D. H. (1979) · PubMed · Cited by 143
COHORT STUDY OF INTESTINAL INFECTION WITH CAMPYLOBACTER IN MEXICAN CHILDREN
Calva, J. J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91297-4 · Cited by 138
Severe acute axonal form of Guillain–Barré syndrome associated with IgG anti‐GD1a antibodies
Yuki, N., Yoshino, H., Sato, S., Shinozawa, K., & Miyatake, T. (1992) · Muscle & Nerve · doi:10.1002/mus.880150806 · Cited by 137
Aspinall, G. O., McDonald, A. G., Raju, T. S., Pang, H., Moran, A. P., & Penner, J. L. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17849.x · Cited by 137
The clinical correlates of high‐titer IgG anti‐GM1 antibodies
Kornberg, A. J., Pestronk, A., Bieser, K., Ho, T. W., McKhann, G. M., Wu, H., & Jiang, Z. (1994) · Annals of Neurology · doi:10.1002/ana.410350217 · Cited by 136
Self-citationCampylobacter jejuni lipopolysaccharides in Guillain-Barre syndrome
Sheikh, K. A., Nachamkin, I., Ho, T. W., Willison, H. J., Veitch, J., Ung, H., Nicholson, M. A., Li, C. Y., Wu, H., Shen, B., et al. (1998) · Neurology · doi:10.1212/wnl.51.2.371 · Cited by 135
Self-citationSalloway, S., Mermel, L. A., Seamans, M., Aspinall, G. O., Shin, J. E. N., Kurjanczyk, L. A., & Penner, J. L. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.2945-2949.1996 · Cited by 126
Oomes, P. G., Jacobs, B. C., Hazenberg, M. P., Bänffer, J. R. J., & van der Meché, F. G. A. (1995) · Annals of Neurology · doi:10.1002/ana.410380208 · Cited by 122
Epidemic campylobacteriosis associated with a community water supply.
Sacks, J. J., Lieb, S., Baldy, L. M., Berta, S., Patton, C. M., White, M. C., Bigler, W. J., & WITTE, J. J. (1986) · American Journal of Public Health · doi:10.2105/ajph.76.4.424 · Cited by 120
Ho, T. W., McKhann, G. M., & Griffin, J. W. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.187 · Cited by 116
Self-citationPlasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.
(1985) · PubMed · Cited by 116
Association of IgG anti‐GD1a antibody with severe Guillain–Barré syndrome
Yuki, N., Yamada, M., Sato, S., et al. (1993) · Muscle & Nerve · doi:10.1002/mus.880160610 · Cited by 114
Ogawa‐Goto, K., Funamoto, N., Ohta, Y., et al. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11018.x · Cited by 110
Localization of GM1 and Gal(β1‐3)GalNAc antigenic determinants in peripheral nerve
Corbo, M., Quattrini, A., Latov, N., & Hays, A. P. (1993) · Neurology · doi:10.1212/wnl.43.4.809 · Cited by 107
Rees, J. H., Vaughan, R. W., Kondeatis, E., & Hughes, R. A. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00102-8 · Cited by 103
Taylor, D. N., Echeverria, P. D., PITARANGSI, C., SERIWATANA, J., Bodhidatta, L., & Blaser, M. J. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.5.863-868.1988 · Cited by 99
Yuki, N., Taki, T., Takahashi, M., Saito, K., Tai, T., Miyatake, T., & Handa, S. (1994) · Infection and Immunity · doi:10.1128/iai.62.5.2101-2103.1994 · Cited by 99
Guillain-Barr� syndrome: Its epidemiology and associations with influenza vaccination
Schonberger, L. B., Hurwitz, E. S., Katona, P. G., Holman, R. C., & Bregman, D. J. (1981) · Annals of Neurology · doi:10.1002/ana.410090707 · Cited by 98
Anti‐gal‐C antibody in autoimmune neuropathies subsequent to mycoplasma infection
Kusunoki, S., Chiba, A., Hitoshi, S., et al. (1995) · Muscle & Nerve · doi:10.1002/mus.880180407 · Cited by 96
Ilyas, A. A., Dalakas, M. C., Brady, R. O., & Quarles, R. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)91540-4 · Cited by 92
HLA antigens in the Landry‐Guillain‐Barré syndrome and chronic relapsing polyneuritis
Stewart, G. J., Pollard, J. D., McLeod, J. G., & Wolnizer, C. M. (1978) · Annals of Neurology · doi:10.1002/ana.410040317 · Cited by 85
The lipopolysaccharide biosynthesis locus of Campylobacter jejuni 81116
Fry, B. N., Korolik, V., ten Brinke, A., et al. (1998) · Microbiology · doi:10.1099/00221287-144-8-2049 · Cited by 83
Triggs, W. J., CROS, D., Gominak, S. C., Zúñiga, G., Berić, A., Shahani, B. T., Ropper, A. H., & Roongta, S. M. (1992) · Brain · doi:10.1093/brain/115.5.1291 · Cited by 81
Clinical Features of Sporadic Campylobacter Infections in Norway
Kapperud, G., Lassen, J. F., Ostroff, S. M., & Aasen, S. (1992) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549209062459 · Cited by 80
Valenstein, P. N., Pfaller, M. A., & Yungbluth, M. (1996) · PubMed · Cited by 79
Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide
Aspinall, G. O., McDonald, A. G., Raju, T. S., Pang, H., Kurjanczyk, L. A., Penner, J. L., & Moran, A. P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17850.x · Cited by 78
Guillain‐Barré Syndrome in South Africa Associated withCampylobacter jejuniO:41 Strains
Lastovica, A. J., Goddard, E., & Argent, A. C. (1997) · The Journal of Infectious Diseases · doi:10.1086/513796 · Cited by 77
Cellular uptake of exogenous horseradish peroxidase in mouse peripheral nerve
Arvidson, B. (1977) · Acta Neuropathologica · doi:10.1007/bf00684538 · Cited by 76
Koski, C. L., Chou, D. K. H., & Jungalwala, F. B. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114152 · Cited by 75
Li, C. Y., Xue, P., Tian, W. Q., et al. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.3.279 · Cited by 73
Yuki, N., Takahashi, M., Tagawa, Y., Kashiwase, K., Tadokoro, K., & Sairo, K. (1997) · Annals of Neurology · doi:10.1002/ana.410420107 · Cited by 70
The Physiology of peripheral nerve disease
Sumner, A. J. (1980) · Saunders eBooks · Cited by 69
Occurrence, clinical manifestations, and prognosis of Guillain-Barre syndrome.
Rantala, H., Uhari, M. K., & Niemelä, M. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.6.706 · Cited by 68
HLA‐B35 and acute axonal polyneuropathy following Campylobacter infection
Yuki, N., Sato, S., Itoh, T., & Miyatake, T. (1991) · Neurology · doi:10.1212/wnl.41.10.1561 · Cited by 65
Buchwald, B., Weishaupt, A., Toyka, K. V., et al. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12155-2 · Cited by 63
Moran, A. P., Appelmelk, B. J., & Aspinall, G. O. (1996) · Journal of Endotoxin Research · doi:10.1177/096805199600300611 · Cited by 63
Identification of Gal(β1–3)GalNAc bearing glycoproteins at the nodes of ranvier in peripheral nerve
Apostolski, S. K., Sadiq, S. A., Hays, A. G., Corbo, M., Suturkova-Milosevic, L., Chaliff, P., Stefánsson, K., LeBaron, R. G., Ruoslahti, E. I., Hays, A. P., et al. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490380203 · Cited by 62
Yuki, N., Handa, S., Tai, T., Takahashi, M., SAITO, K., Tsujino, Y., & Taki, T. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00045-4 · Cited by 53
HLA-DR antigens in Mexican patients with Guillain-Barré syndrome
Gorodezky, C., Varela, B., Castro‐Escobar, L. E., et al. (1983) · Journal of Neuroimmunology · doi:10.1016/0165-5728(83)90058-9 · Cited by 53
Sawant‐Mane, S., Clark, M. B., & Koski, C. L. (1991) · Annals of Neurology · doi:10.1002/ana.410290410 · Cited by 53
Prognosis in Guillain-Barre syndrome.
Briscoe, D. M., McMenamin, J. B., & O’Donohoe, N. V. (1987) · Archives of Disease in Childhood · doi:10.1136/adc.62.7.733 · Cited by 50
Serologic Evidence of Campylobacter jejuni/coli Enteritis in Patients with Guillain-Barre Syndrome
Gruenewald, R., Ropper, A. H., Lior, H., Chan, J., Lee, R., & Molinaro, V. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530220102027 · Cited by 50
Prognosis in severe Guillain-Barre syndrome.
Cole, G., & Matthew, D. J. (1987) · Archives of Disease in Childhood · doi:10.1136/adc.62.3.288 · Cited by 47
Differential Distribution of HLA Alleles in Two Forms of Guillain‐Barré Syndrome
Monos, D. S., Papaioakim, M., Ho, T. W., Li, C. Y., & McKhann, G. M. (1997) · The Journal of Infectious Diseases · doi:10.1086/513786 · Cited by 45
Self-citationClinical correlation with serum‐soluble interleukin‐2 receptor levels in Guillain‐Barré syndrome
Bansil, S., Mithen, F. A., Cook, S. D., Sheffet, A., & Rohowsky‐Kochan, C. (1991) · Neurology · doi:10.1212/wnl.41.8.1302 · Cited by 42
Mato, M., Ookawara, S., Sugamata, M., & Aikawa, E. (1984) · Cellular and Molecular Life Sciences · doi:10.1007/bf01952574 · Cited by 39
Pathogenesis of axonal Guillain–Barré syndrome: Hypothesis
Yuki, N. (1994) · Muscle & Nerve · doi:10.1002/mus.880170619 · Cited by 39
There are no neurophysiologic features characteristic of “axonal” Guillain–Barré syndrome
Cros, D. P., & Triggs, W. J. (1994) · Muscle & Nerve · doi:10.1002/mus.880170617 · Cited by 37
HLA ANTIGENS IN GUILLAIN-BARRÉSYNDROME
Adams, D., Gibson, J., Thomas, P. K., Batchelor, J. R., Hughes, R. A., Kennedy, L. J., Festenstein, H., & Sachs, J. A. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91626-9 · Cited by 33
HLA and anti-GQ1b IgG antibody in Miller Fisher syndrome and Guillain-Barré syndrome
Chiba, A., Kusunoki, S., Kuwata, S., et al. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00079-h · Cited by 23
Cited by
The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences
Parkhill, J., Wren, B. W., Mungall, K., Ketley, J. M., Churcher, C., Basham, D., Chillingworth, T., Davies, R. M., Feltwell, T., Holroyd, S., et al. (2000) · Nature · doi:10.1038/35001088 · Cited by 1,976
Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B. C., & van Doorn, P. A. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.121 · Cited by 1,101
Practice Guidelines for the Management of Infectious Diarrhea
Guerrant, R. L., Van Gilder, T., Steiner, T. S., Thielman, N. M., Slutsker, L., Tauxe, R. V., Hennessy, T., Griffin, P. M., DuPont, H., Bradley Sack, R., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/318514 · Cited by 1,074
Self-citationMultilocus Sequence Typing System for Campylobacter jejuni
Dingle, K. E., Colles, F. M., Wareing, D. R. A., Ure, R., Fox, A. J., Bolton, F. E., Bootsma, H. J., Willems, R. J. L., Urwin, R., & Maiden, M. C. J. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.14-23.2001 · Cited by 852
The role of microbiome in central nervous system disorders
Wang, Y., & Kasper, L. H. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.12.015 · Cited by 803
Metadata
- Authors
- Nachamkin, I., Allos, B. M., & Ho, T.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1998-07
- Volume
- 11
- Issue
- 3
- Pages
- 555-567
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2166211924
- Cited by
- 590
- References
- 112
- FWCI
- 13.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.